Filter Results:
(9,277)
Show Results For
- All HBS Web
(9,277)
- People (18)
- News (2,527)
- Research (5,008)
- Events (55)
- Multimedia (180)
- Faculty Publications (3,843)
Show Results For
- All HBS Web
(9,277)
- People (18)
- News (2,527)
- Research (5,008)
- Events (55)
- Multimedia (180)
- Faculty Publications (3,843)
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- August 2013 (Revised November 2013)
- Supplement
Ford vs. GM: The Evolution of Mass Production (B)
By: Willy Shih
This case explores the very different paths taken by the Ford Motor Company and the General Motors Corporation in the first three decades of the twentieth century. Henry Ford's Model T was a car for the masses. After considerable experimentation, Ford Motor... View Details
Keywords: Innovation; Exploration; Dominant Design; Business Growth and Maturation; Business History; Innovation and Management; Innovation Strategy; Technological Innovation; Leading Change; Growth and Development Strategy; Product Positioning; Product Design; Product Development; Business Strategy; Corporate Strategy; Vertical Integration; Auto Industry; Manufacturing Industry; Michigan
Shih, Willy. "Ford vs. GM: The Evolution of Mass Production (B)." Harvard Business School Supplement 614-011, August 2013. (Revised November 2013.)
- 2008
- Working Paper
Using Financial Innovation to Support Savers: From Coercion to Excitement
By: Peter Tufano
We review a wide variety of programs that support savings by families, in particular by low- and moderate-income families. These programs range from ones that literally compel families to save, to those that make it hard not to save, make it easier to save, provide... View Details
Keywords: Saving; Motivation and Incentives; Programs; Income; Personal Finance; Family and Family Relationships; Performance Effectiveness
Tufano, Peter, and Daniel Schneider. "Using Financial Innovation to Support Savers: From Coercion to Excitement." Harvard Business School Working Paper, No. 08-075, April 2008.
- 10 Feb 2020
- News
The Gneralist, Not the Specialist, is the Likely Innovator
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
to answer: Would negative publicity from the accident affect future innovation in that segment of the medical device industry? Would people’s perception of safety issues reduce... View Details
- Web
Managing and Innovating in Financial Services - Course Catalog
system: they are the only entities that can hold accounts at the Federal Reserve and are thus critical in money movement across the financial system. And you can’t really understand innovation and tech disruption without understanding the... View Details
- April 1993 (Revised October 1995)
- Case
ALZA and Bio-Electro Systems (A): Technological and Financial Innovation
By: Josh Lerner and Peter Tufano
To develop the next generation of risky products, ALZA, a mature and profitable biotechnology firm specializing in drug delivery systems, must raise $40 million. Organizational constraints and competitive concerns demand that the work be done inside the firm. However,... View Details
Keywords: Risk and Uncertainty; Technological Innovation; Business Subsidiaries; Decision Choices and Conditions; Corporate Finance; Biotechnology Industry; Medical Devices and Supplies Industry
Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (A): Technological and Financial Innovation." Harvard Business School Case 293-124, April 1993. (Revised October 1995.)
- Forthcoming
- Article
Confronting the Limits of Symbolic Actions: How Entrepreneurs Narrow the Presentation-Performance Gap
By: Rebecca Karp and Siobhan O'Mahony
Entrepreneurs often skillfully leverage symbolic actions to manage impressions and gain acceptance for their innovations. Impression management can generate interest, but also heighten expectations beyond an innovation’s capabilities, creating a gap between... View Details
- December 2017
- Case
International Institute of Tropical Agriculture
By: Jose B. Alvarez and Sarah Mehta
It is July 2017, and Dr. Nteranya Sanginga, the director general of the Nigeria-based International Institute of Tropical Agriculture (IITA), is making progress toward two of his primary strategic objectives for the nonprofit research Institute: 1) to scale the impact... View Details
Keywords: Scaling Technologies; Youth Unemployment; Innovation In Nonprofits; Agribusiness; Plant-Based Agribusiness; Cash Flow; Labor; Employment; Commercialization; Problems and Challenges; Agriculture and Agribusiness Industry; Africa; Nigeria
Alvarez, Jose B., and Sarah Mehta. "International Institute of Tropical Agriculture." Harvard Business School Case 518-034, December 2017.
- Web
Accelerating Innovation | Social Enterprise | Harvard Business School
As social entrepreneurship has taken on increasing prominence over the past two decades, HBS alumni have been at the forefront of change from starting new organizations and embedding an entrepreneurial spirit within established ones to... View Details
- 01 Mar 2012
- News
Get Creative
Issue Focus: Innovation In a hypercompetitive global economy, creativity has never been more important for success . But how do you create a company that unleashes and capitalizes on innovation? For answers, we turned to five HBS faculty experts in culture, customers,... View Details
- January 2008
- Article
Innovation Killers: How Financial Tools Destroy Your Capacity to Do New Things
By: Clayton M. Christensen, Stephen P. Kaufman and Willy C. Shih
Most companies aren't half as innovative as their senior executives want them to be (or as their marketing claims suggest they are). What's stifling innovation? There are plenty of usual suspects, but the authors finger three financial tools as key accomplices.... View Details
Keywords: Investment; Innovation and Management; Growth and Development Strategy; Business and Shareholder Relations; Prejudice and Bias; Value Creation
Christensen, Clayton M., Stephen P. Kaufman, and Willy C. Shih. "Innovation Killers: How Financial Tools Destroy Your Capacity to Do New Things." Special Issue on HBS Centennial. Harvard Business Review 86, no. 1 (January 2008).
- 1999
- Book
Marketing Kakushin no Jidai 2: Seihin Kaihatsu Kakushin (The Age of Marketing Innovation 2: Product Development Innovation)
By: Mitsuaki Shimaguchi, Hirotaka Takeuchi, Hotaka Katahira and Junzou Ishii
- 11 Mar 2014
- News
3 Ways to Innovate in a Stagnant Environment
- March 2010 (Revised January 2011)
- Case
Carrot or Stick? Getting Paid for Innovation at Tessera Technologies
By: Willy C. Shih
Tessera Technologies has been very successful developing technologies for the semiconductor and mobile device industry, and then licensing them broadly to manufacturers. In addition to licensing patents, it also supplies know-how to help manufacturers move into... View Details
Keywords: Business Model; Innovation Strategy; Patents; Courts and Trials; Rights; Mobile Technology; Semiconductor Industry; California
Shih, Willy C. "Carrot or Stick? Getting Paid for Innovation at Tessera Technologies." Harvard Business School Case 610-085, March 2010. (Revised January 2011.)
- 16 Sep 2021
- News
Dean Datar on Design Thinking and Innovative Problem Solving
Courtesy Patrick McGinnis Courtesy Patrick McGinnis Dean Srikant Datar recently spoke to author, podcast host, and venture capitalist Patrick McGinnis (MBA 2004) about design thinking and innovative problem solving as part View Details
Divestment or Engagement? New Research on Innovation in the Energy Sector
Why you should watch: A new and important NBER working paper, by Cohen, Gurun and Nguyen, takes a long hard look at innovation in the energy industry - and concludes that divestment campaigns targeted at fossil fuel companies may not just be ineffective.... View Details
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- 25 Aug 2016
- News